152 related articles for article (PubMed ID: 16757696)
1. Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs.
Vastag B
J Natl Cancer Inst; 2006 Jun; 98(11):733-5. PubMed ID: 16757696
[No Abstract] [Full Text] [Related]
2. Antiestrogens: the past and the future.
Bentrem DJ; Jordan VC
Zentralbl Gynakol; 2002 Dec; 124(12):551-8. PubMed ID: 12822068
[No Abstract] [Full Text] [Related]
3. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
4. Chemoprevention of breast cancer: recommendations and rationale.
Berg AO;
Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
[No Abstract] [Full Text] [Related]
5. Drugs can reduce the incidence of breast cancer: now what?
Wozniak TF; Eppes PG; Wilson CT
Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
[No Abstract] [Full Text] [Related]
6. Defining the role of raloxifene for the prevention of breast cancer.
Kalidas M; Hilsenbeck S; Brown P
J Natl Cancer Inst; 2004 Dec; 96(23):1731-3. PubMed ID: 15572750
[No Abstract] [Full Text] [Related]
7. Tamoxifen: an enduring star.
Veronesi U; Maisonneuve P; Decensi A
J Natl Cancer Inst; 2007 Feb; 99(4):258-60. PubMed ID: 17312297
[No Abstract] [Full Text] [Related]
8. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
Jordan VC
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
[No Abstract] [Full Text] [Related]
9. [Antiestrogens: mechanism of action and clinical applications].
Barrón-González A; Arias-Martínez J; Castro-Romero I
Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
Fabian C
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
[No Abstract] [Full Text] [Related]
11. [Additional effect of SERM: mammary gland].
Kurebayashi J
Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
[TBL] [Abstract][Full Text] [Related]
12. The Study of Tamoxifen and Raloxifene (STAR trial) for the prevention of breast cancer.
Kelminski A
Hawaii Med J; 2002 Sep; 61(9):209-10. PubMed ID: 12422387
[No Abstract] [Full Text] [Related]
13. The current status of breast cancer chemoprevention: a star is born.
Morrow M; Jordan VC
J Surg Oncol; 2007 Jan; 95(1):4-5. PubMed ID: 17192883
[No Abstract] [Full Text] [Related]
14. Targeted antiestrogens for the prevention of breast cancer.
Bentrem DJ; Jordan VC
Oncol Res; 1999; 11(9):401-7. PubMed ID: 10821534
[TBL] [Abstract][Full Text] [Related]
15. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB
J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
[TBL] [Abstract][Full Text] [Related]
16. Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
Jordan VC
Eur J Cancer; 2006 Nov; 42(17):2909-13. PubMed ID: 17064889
[TBL] [Abstract][Full Text] [Related]
17. Chemoprevention of breast cancer: recommendations and rationale.
Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
[No Abstract] [Full Text] [Related]
18. Budget impact analysis of chemoprevention of breast cancer with tamoxifen and raloxifene among high-risk women in Japan.
Kondo M; Hoshi SL; Toi M
Jpn J Clin Oncol; 2009 Nov; 39(11):767-70. PubMed ID: 19656807
[TBL] [Abstract][Full Text] [Related]
19. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
20. Hormonal interventions to prevent hormonal cancers: breast and prostate cancers.
Dunn BK; Ford LG
Eur J Cancer Prev; 2007 Jun; 16(3):232-42. PubMed ID: 17415094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
